JAMA Dermatology —The Year in Review, 2025 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

JAMA Dermatology: Highlights and Developments from 2025

  • By

  • Kanade Shinkai

  • May 1, 2026

Share

Objective:

To summarize the key developments and performance metrics of JAMA Dermatology in 2025.

Key Findings:
  • The impact factor remained high at 11.
  • The article on nicotinamide supplementation showed potential benefits for skin cancer prevention.
  • AI applications in dermatology were highlighted, including studies on wearable devices providing haptic feedback and risk stratification tools for cutaneous squamous cell carcinoma.
Interpretation:

The journal's focus on timely publication and high-quality research continues to enhance its relevance in dermatology.

Limitations:
  • The need for prospective randomized clinical trials to confirm findings on nicotinamide.
  • Potential overdiagnosis issues in melanoma screening were discussed, emphasizing the need for careful evaluation.
Conclusion:

JAMA Dermatology is committed to publishing impactful research that informs clinical practice while adapting to evolving challenges in dermatology.

Original Source(s)

JAMA Dermatology —The Year in Review, 2025

  • by Kanade Shinkai

  • May 1, 2026

Related Content

FDA Permits New Sunscreen Ingredient After 20 Years

The sunscreen ingredient, which has been marketed internationally for years, is considered generally recognized as safe and effective for use in adults and pediatric patients aged 6 months and older.

Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study

What shapes patient attitudes toward TBP skin cancer screening?

Expert consensus highlights communication, privacy, and staff interactions as priorities for a proposed patient-reported experience measure.